Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes

About this episode

Hannah Robinson discusses her experience as the first adult in the UK to receive the immunotherapy drug Teplizumab to delay Type 1 diabetes onset.

Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip. Send a text

People in this episode

Hosts: Andrew Hattersley, Maggie Shepherd

Guest: Hannah Robinson

Topics covered

• immunotherapy
• Type 1 diabetes
• healthcare
• medical treatment
• adult-onset diabetes

Keywords

• immunotherapy
• Teplizumab
• Type 1 diabetes
• Hannah Robinson
• Nick Thomas
• healthcare
• autoantibodies

Mentioned in this episode

Products: Teplizumab

Places: UK

More episodes of One in Six Billion

• Special Episode 8: Steve Chapman, Andrew Hattersley and Maggie Shepherd. Final reflections on making the One in Six billion podcast. · October 28, 2025 · 25 min
• Series 4 Episode 8. Rohini Bajekal and Shivani Misra. The challenge of diagnosing monogenic diabetes in South Asians · October 14, 2025 · 36 min
• Series 4 episode 7. Sarah Richardson. Small extra-islet beta cells matter · September 30, 2025 · 21 min
• Series 4 episode 5. Jerry Gore and Rob Andrews. Living life on the edge with Type 1 diabetes. · September 2, 2025 · 35 min
• Series 4 episode 4. Chris Bright and Rob Andrews. Type 1 diabetes and Elite Sport. · August 19, 2025 · 37 min
• Series 4 episode 3: Hannah Robinson and Nick Thomas · August 5, 2025 · 26 min